• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 于血液透析患者:五例报告。

COVID-19 in Hemodialysis Patients: A Report of 5 Cases.

机构信息

Department of Nephrology, Zhongnan Hospital, Wuhan University, Wuhan, China.

Laboratory Medicine, Zhongnan Hospital, Wuhan University, Wuhan, China.

出版信息

Am J Kidney Dis. 2020 Jul;76(1):141-143. doi: 10.1053/j.ajkd.2020.03.009. Epub 2020 Mar 31.

DOI:10.1053/j.ajkd.2020.03.009
PMID:32240718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118604/
Abstract

In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this case report, we describe the clinical and epidemiologic features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 patients with COVID-19 infection, one had a definite history of contact with an infected person. The age range of the patients was 47 to 67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients. Computed tomography of the chest showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, or multiple organ dysfunction) or died.

摘要

2019 年 12 月,一种由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)在中国爆发,并迅速在全球范围内传播。目前尚不清楚血液透析患者是否代表一组具有某些特征的特定患者,这些特征可能使他们容易感染或患上严重疾病。在本病例报告中,我们描述了武汉大学中南医院 201 例维持性血液透析患者 COVID-19 感染的临床和流行病学特征,包括 5 例确诊为 COVID-19 感染的维持性血液透析患者。在 5 例 COVID-19 感染患者中,有 1 例有明确的与感染者接触史。患者年龄为 47 至 67 岁。腹泻(80%)、发热(60%)和乏力(60%)是最常见的症状。所有患者均出现淋巴细胞减少症。胸部计算机断层扫描显示所有患者肺部均有磨玻璃样混浊。截至 2020 年 2 月 13 日,尚无患者发生严重并发症(急性呼吸窘迫综合征、休克或多器官功能障碍)或死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2095/7118604/523c1f75b9e7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2095/7118604/523c1f75b9e7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2095/7118604/523c1f75b9e7/gr1_lrg.jpg

相似文献

1
COVID-19 in Hemodialysis Patients: A Report of 5 Cases.COVID-19 于血液透析患者:五例报告。
Am J Kidney Dis. 2020 Jul;76(1):141-143. doi: 10.1053/j.ajkd.2020.03.009. Epub 2020 Mar 31.
2
Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.血清学检测在血液透析中心的 SARS-CoV-2 感染: 在中国武汉的一项多中心回顾性研究。
Am J Kidney Dis. 2020 Oct;76(4):490-499.e1. doi: 10.1053/j.ajkd.2020.06.008. Epub 2020 Jul 3.
3
Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People's Republic of China.新型冠状病毒肺炎患者行肺切除术的围手术期管理:来自中国武汉某胸外科的简要报告
J Thorac Oncol. 2020 Jun;15(6):1065-1072. doi: 10.1016/j.jtho.2020.04.003. Epub 2020 Apr 11.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.中国武汉维持性血液透析患者 2019 年新型冠状病毒肺炎的临床特征。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1139-1145. doi: 10.2215/CJN.04160320. Epub 2020 May 22.
6
Coronavirus Disease 2019 in a Hemodialysis Patient.新型冠状病毒肺炎合并血液透析患者一例
Blood Purif. 2020;49(6):761-764. doi: 10.1159/000507877. Epub 2020 Apr 27.
7
Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report.一名血液透析患者同时感染新冠病毒和副流感病毒:病例报告
Clin Nephrol. 2020 Oct;94(4):207-211. doi: 10.5414/CN110164.
8
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
9
Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.中国武汉血液透析患者 COVID-19 的临床特征和医学干预措施。
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397. doi: 10.1681/ASN.2020030354. Epub 2020 May 8.
10
SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases.SARS-CoV-2 感染相关的慢性肾脏病患者急性肾损伤:两例报告。
Immun Inflamm Dis. 2020 Dec;8(4):506-511. doi: 10.1002/iid3.333. Epub 2020 Jul 28.

引用本文的文献

1
Review of clinical characteristics and mortality outcomes in patients on maintenance hemodialysis during the Omicron surge: a single center experience.奥密克戎变异株流行期间维持性血液透析患者的临床特征和死亡结局回顾:一项单中心经验。
BMC Public Health. 2024 Jun 3;24(1):1481. doi: 10.1186/s12889-024-18999-5.
2
COVID - 19 in two dialysis centers situated in two neighbouring states of the Western Balkans.巴尔干西部两个相邻州的两家透析中心的 COVID-19 疫情。
BMC Nephrol. 2023 Feb 18;24(1):40. doi: 10.1186/s12882-023-03080-x.
3
Characterization of regulatory T cells in SARS-CoV-2 infected hemodialysis patients: relation to clinical and radiological severity.

本文引用的文献

1
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?新冠病毒与透析单位:我们目前了解到了什么以及我们应该怎么做?
Am J Kidney Dis. 2020 Jul;76(1):1-3. doi: 10.1053/j.ajkd.2020.03.008. Epub 2020 Mar 23.
2
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.法国 2019 年冠状病毒病(COVID-19)的首批病例:2020 年 1 月的监测、调查和控制措施。
Euro Surveill. 2020 Feb;25(6). doi: 10.2807/1560-7917.ES.2020.25.6.2000094.
3
The first 2019 novel coronavirus case in Nepal.
描述 SARS-CoV-2 感染血液透析患者的调节性 T 细胞:与临床和影像学严重程度的关系。
BMC Nephrol. 2022 Dec 7;23(1):391. doi: 10.1186/s12882-022-03024-x.
4
Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients.日本第6波新冠疫情在血液透析患者中的特征
Ren Replace Ther. 2022;8(1):61. doi: 10.1186/s41100-022-00451-2. Epub 2022 Dec 2.
5
Evaluation of hemodialysis patients and hemodialysis health workers with COVID-19 IgM and IgG antibody test; a multicenter study from Eskisehir, Turkiye.采用新冠病毒 IgM 和 IgG 抗体检测评估血液透析患者及血液透析医护人员;来自土耳其埃斯基谢希尔的一项多中心研究。
North Clin Istanb. 2022 Oct 27;9(5):476-783. doi: 10.14744/nci.2021.62447. eCollection 2022.
6
Effectiveness of hemoperfusion (HP) in hemodialysis (HD) patients with Covid-19 infection.血液灌流(HP)在 COVID-19 感染血液透析(HD)患者中的疗效。
Transfus Apher Sci. 2022 Dec;61(6):103589. doi: 10.1016/j.transci.2022.103589. Epub 2022 Oct 28.
7
Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study.磷酸盐和白细胞介素-10 浓度可预测血液透析患者的长新冠:巴西研究。
Front Immunol. 2022 Sep 30;13:1006076. doi: 10.3389/fimmu.2022.1006076. eCollection 2022.
8
COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab.接受奥马珠单抗治疗的低补体血症性荨麻疹综合征和MPO-ANCA血管炎血液透析患者的新型冠状病毒肺炎
Nefrologia (Engl Ed). 2021 May-Jun;41(3):354-355. doi: 10.1016/j.nefroe.2020.07.003. Epub 2021 Jul 21.
9
COVID-19 incidence and outcomes in a home dialysis unit in Madrid (Spain) at the height of the pandemic.在大流行期间,马德里(西班牙)家庭透析单位的 COVID-19 发病率和结果。
Nefrologia (Engl Ed). 2021 May-Jun;41(3):329-336. doi: 10.1016/j.nefroe.2020.09.009. Epub 2021 Aug 19.
10
Vaccination and COVID-19 in Polish Dialysis Patients: Results from the European Clinical Dialysis Database.波兰透析患者的疫苗接种与新冠病毒病:来自欧洲临床透析数据库的结果
Vaccines (Basel). 2022 Sep 19;10(9):1565. doi: 10.3390/vaccines10091565.
尼泊尔首例2019新型冠状病毒病例。
Lancet Infect Dis. 2020 Mar;20(3):279-280. doi: 10.1016/S1473-3099(20)30067-0. Epub 2020 Feb 10.
4
COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020).2019冠状病毒病,澳大利亚:流行病学报告2(截至澳大利亚东部夏令时2020年2月8日19:00的报告周)
Commun Dis Intell (2018). 2020 Feb 12;44. doi: 10.33321/cdi.2020.44.14.
5
A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan.台湾地区一起新型冠状病毒肺炎本地传播病例。
N Engl J Med. 2020 Mar 12;382(11):1070-1072. doi: 10.1056/NEJMc2001573. Epub 2020 Feb 12.
6
Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.2020 年 1 月 20 日至 28 日,中国武汉旅行者感染 2019 年新型冠状病毒(2019-nCoV)的潜伏期。
Euro Surveill. 2020 Feb;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.2000062.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
9
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
10
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.新型冠状病毒持续的2019 - nCoV疫情对全球健康构成威胁——中国武汉最新的2019新型冠状病毒爆发。
Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14.